Zhuzhou Qianjin Pharmaceutical Co.,Ltd.’s Net Profit Rose 4.1% in First Half of 2023

Zhuzhou Qianjin Pharmaceutical Co.,Ltd. (株洲千金药业股份有限公司) (600479.SH) reported a net profit of 144.3 million yuan in the first half of 2023, up 4.1% year-on-year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 0.1% year-on-year.

At the end of the reporting period, it had 4.4 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 36.1%.